WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] Voir le document au format PDF
Table des matières
Afficher le documentPreface
Afficher le documentIntroduction
Ouvrir ce répertoire et afficher son contenuParasitic infections
Ouvrir ce répertoire et afficher son contenuInsect and arachnid bites and stings
Ouvrir ce répertoire et afficher son contenuSuperficial fungal infections
Ouvrir ce répertoire et afficher son contenuSubcutaneous fungal infections
Ouvrir ce répertoire et afficher son contenuBacterial infections
Ouvrir ce répertoire et afficher son contenuViral infections
Ouvrir ce répertoire et afficher son contenuEczematous diseases
Ouvrir ce répertoire et afficher son contenuScaling diseases
Ouvrir ce répertoire et afficher son contenuPapulosquamous diseases
Afficher le documentCutaneous reactions to drugs
Ouvrir ce répertoire et afficher son contenuPigmentary disorders
Ouvrir ce répertoire et afficher son contenuPremalignant lesions and malignant tumours
Ouvrir ce répertoire et afficher son contenuPhotodermatoses
Ouvrir ce répertoire et afficher son contenuBullous dermatoses
Afficher le documentAlopecia areata
Afficher le documentUrticaria
Ouvrir ce répertoire et afficher son contenuConditions common in children
Afficher le documentAcne vulgaris
Afficher le documentPruritus
Afficher le documentTropical ulcers
Ouvrir ce répertoire et afficher son contenuAntimicrobial drugs
Ouvrir ce répertoire et afficher son contenuAntifugal drugs
Ouvrir ce répertoire et afficher son contenuAntiseptic agents
Fermer ce répertoireKeratoplastic and keratolytic agents
Afficher le documentBenzoyl peroxide
Afficher le documentCoal tar
Afficher le documentDithranol
Afficher le documentSalicylic acid
Afficher le documentTretinoin
Ouvrir ce répertoire et afficher son contenuScabicides and pediculicides
Ouvrir ce répertoire et afficher son contenuAnti-inflammatory and antipruritic drugs1
Ouvrir ce répertoire et afficher son contenuAntiallergics and drugs used in anaphylaxis
Ouvrir ce répertoire et afficher son contenuUltraviolet radiation-blocking agents (sunscreens)
Ouvrir ce répertoire et afficher son contenuMiscellaneous drugs
Ouvrir ce répertoire et afficher son contenuAnnex
Afficher le documentSelected WHO Publications of Related Interest
Afficher le documentBack cover
 

Benzoyl peroxide

Cream or lotion, 2.5%, 5%, 10%

General information

Benzoyl peroxide is a bacteriostatic agent that is used primarily in acne because of its activity against Propionibacterium acnes.

It is absorbed by the skin after topical application and metabolized to benzoic acid.

Clinical information

Uses

Treatment of mild to moderate acne vulgaris and as an adjunct to therapy in more severe cases.

Dosage and administration

Adults and adolescents: a thin layer of 2.5% or 5% cream or lotion should be applied to clean skin initially once daily on alternate days. The frequency of application is then gradually increased up to twice daily as tolerance develops. Unresponsive cases may require treatment with the 10% preparation.

Contraindications

Known hypersensitivity to benzoyl peroxide.

Precautions

Benzoyl peroxide should not be applied to open sores or broken skin. Contact with the eyes and mucous membranes should be avoided.

Use in pregnancy

Topically applied benzoyl peroxide is not systemically absorbed and can be used safely during pregnancy.

Adverse effects

Skin irritation is common after topical application but subsides with continued treatment.

Rarely, contact sensitivity has been reported.

Storage

Preparations should be stored in well-closed containers. They should not be allowed to freeze.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 24 avril 2012